Eastwood

[Eastwood @TPry001]

@phoenicianstrat @a_a_free Let's see

[Eastwood @TPry001]

@a_a_free @phoenicianstrat Agree

[Eastwood @TPry001]

@a_a_free @phoenicianstrat After BI and Bayer data and approvals, this asset is to be valued differently. ERBB2 differentiates per BBB penetratibility whilst pik3 one was designed to stay away from the CNS and may still play out. JAK and RAS inh. next but why drag their INDs?💡

[Eastwood @TPry001]

@a_a_free @phoenicianstrat It ain't ERBB2 but FGFR..winding down lol

[Vivek Subbiah, MD @VivekSubbiah]

🚨While @SpaceX goes IPO and the world's glued to @FIFAWorldCup ⚽🚀an interesting paper popped up for your Friday read @NatureMedicine
👉Frontier general LLMs (GPT-5.2, Gemini 3.1 Pro, Claude Opus 4.6) outperformed specialized clinical AI tools (OpenEvidence, UpToDate Expert AI) on medical knowledge, clinician alignment + 1,800 blinded physician annotations on real clinical queries🤯
👉This result was unexpected 🤯🤔 👉"Specialized" ≠ "Better" @OncoAlert
https://t.co/B0RmOhIZI2

[Eastwood @TPry001]

@tropicalviking @Liathetrader It must be an Italian village of 10...pff

[Eastwood @TPry001]

@student_luxury6 @Liathetrader @drkeithsiau Ok so you got it wrong, again, as you seem to collect "knowledge" from AI-halos and act out. Lovely.

[Eastwood @TPry001]

@drkeithsiau @Kerry61270370 My husband stopped after 6 months and having shedd 22lb. His BP is normal since 3 months-stopped therapy 2 months ago- weight gain is 1lb. He runs 9k 2-3x a week but that didn't help with the weight loss. BMI was 30, his doc prescribed diet and antihypertensives

[Eastwood @TPry001]

@NamNamArien @drkeithsiau @Doctor_Salomon Same holds true for every drug or nearly every. None of them have been tested for a decade-long use.

[Eastwood @TPry001]

@drkeithsiau @Odelora_ @Abe_Kowo Yes, however many studies with GLP-1 or double (GLP-1/GIP) agonists are out, data is clean and yet admin and or political hurdels are slowing access. This specific case-i support.

[Eastwood @TPry001]

@student_luxury6 @Liathetrader @drkeithsiau Hate to tell you but you are absolutely wrong. It is primarily inflammation-driven and mediators which serves as markers there of are significantly reduced upon use.

[Eastwood @TPry001]

@Biotech2k1 It bundles some of the strongest stock with penny ones. I dropped it except for specific data point search

[Eastwood @TPry001]

@dansemperepico @SullyMichaelvan What is the story w Vitb12? Such broad use and very little in FAERS?

[Eastwood @TPry001]

@Biotech2k1 Cogent biosciences is undervalued and by a large margin. What analysts seem to have overlooked are two things, first it is a company with a good pipeline and a team behind Adagrasib. Second, stellar Bezu data w massive CI tide still rings MA despite recent hirings. Let us see

[Eastwood @TPry001]

@Biotech2k1 Hi, i love your posts. Well informed and spot on.

[Eastwood @TPry001]

@Apheleia9 @Liathetrader Yeah, we've decided to give it s pass and seems like we're not lonely in that corner. Also Europeans' travel funds have thinned which explains the Turkey uptick. Alps are seeing a pretty low ski-season and snow is not the reason.

[Eastwood @TPry001]

@Mishi_2210 1050

[Eastwood @TPry001]

@slaint34e @DieselCane22 @eurofounder @JaylenRMabin I had fun😂😂

[Eastwood @TPry001]

@Mishi_2210 Impossible to know when Ethan had his kid🥱

[Eastwood @TPry001]

@phoenicianstrat @Minervakick001 Exactly. They cemented their spot in GIST much like Novartis did in the 1L.